Acute Asthma Exacerbation Management

Initial Assessment and Treatment

• The American Thoracic Society recommends assessing severity based on symptoms, signs, and lung function (PEF or FEV1) 1
• The British Thoracic Society guidelines define mild exacerbation as dyspnea only with activity, PEF ≥70% of predicted/personal best 1
• The National Asthma Education and Prevention Program defines moderate exacerbation as dyspnea interfering with usual activity, PEF 40-69% of predicted 1
• Severe exacerbation is defined as dyspnea at rest, PEF <40% of predicted, according to the Global Initiative for Asthma 1
• Life-threatening features include confusion, drowsiness, silent chest, cyanosis, as stated by the British Thoracic Society 2, 3

Primary Treatment Components

• The American College of Chest Physicians recommends administering oxygen through nasal cannulae or mask to maintain SaO₂ >90% (>95% in pregnant patients or those with heart disease) 4, 1
• The American Academy of Allergy, Asthma, and Immunology suggests monitoring oxygen saturation continuously until clear response to bronchodilator therapy 1
• Albuterol is the first-line treatment for all asthma exacerbations, according to the National Asthma Education and Prevention Program 1
• The American Thoracic Society recommends nebulizer administration of 2.5-5 mg every 20 minutes for 3 doses, then 2.5-10 mg every 1-4 hours as needed 4, 1
• For severe exacerbations (FEV1 or PEF <40%), continuous administration of albuterol may be more effective, as stated by the American College of Chest Physicians 4, 5

Adjunctive Therapies

• The American Academy of Allergy, Asthma, and Immunology recommends adding ipratropium bromide to SABA therapy for severe exacerbations 4, 1
• The National Asthma Education and Prevention Program suggests dosing ipratropium bromide at 0.5 mg via nebulizer or 8 puffs via MDI every 20 minutes for 3 doses, then as needed 1
• Magnesium sulfate can be considered for patients with severe refractory asthma, according to the American College of Chest Physicians 1
• The standard adult dose of magnesium sulfate is 2 g IV administered over 20 minutes, as recommended by the American Thoracic Society 1

Treatment Strategy and Monitoring

• The American College of Emergency Physicians recommends initial assessment and treatment within the first 15-30 minutes, including oxygen, first dose of albuterol, and systemic corticosteroids 1, 5
• The American Academy of Allergy, Asthma, and Immunology suggests reassessing patients 15-30 minutes after starting treatment 4, 1
• Measuring PEF or FEV₁ before and after treatments is recommended by the National Asthma Education and Prevention Program 1
• Response to treatment is a better predictor of hospitalization need than initial severity, according to the American Thoracic Society 1, 5

Hospital Admission Criteria

• The British Thoracic Society recommends hospital admission for any life-threatening features, such as confusion, drowsiness, silent chest, or cyanosis 2, 3
• The American College of Chest Physicians suggests hospital admission for any features of acute severe asthma present after initial treatment, especially PEF <33% 2, 3
• A lower threshold for admission is recommended if the patient has a history of recent nocturnal symptoms, recent hospital admission, or previous severe attacks, according to the National Asthma Education and Prevention Program 2, 3

Acute Asthma Exacerbation Management

Initial Assessment and Treatment

• The American Thoracic Society recommends assessing severity of asthma exacerbation using symptoms, peak expiratory flow (PEF), and oxygen saturation, and administering oxygen to maintain SaO₂ >90% (>95% in pregnancy/heart disease) 6
• The British Thoracic Society suggests administering systemic corticosteroids immediately, with options including oral dexamethasone or prednisolone, and IV methylprednisolone for severe cases 6

Corticosteroid Dosing

• The American Academy of Pediatrics and the American College of Chest Physicians recommend oral dexamethasone 0.3 mg/kg (maximum 12 mg) as a single dose, or 0.6 mg/kg/day (maximum 16 mg/day) for 2 days, as an alternative to prednisolone 1-2 mg/kg/day (maximum 40-60 mg) for 5 days, for children with acute asthma exacerbation 6
• The National Asthma Education and Prevention Program suggests oral dexamethasone 16 mg daily for 2 days, or prednisolone 30-60 mg daily for 5-10 days, for adults with acute asthma exacerbation 6

Dexamethasone for Asthma Exacerbation

Role of Systemic Corticosteroids in Asthma Exacerbations

• Systemic corticosteroids are the only proven treatment for the inflammatory component of acute asthma exacerbations and should be administered early to all patients with moderate-to-severe exacerbations, with anti-inflammatory effects apparent in 6 to 12 hours, according to the American Heart Association 7, 8, 9
• The American College of Cardiology recommends prompt administration of systemic corticosteroids to hasten resolution of airflow obstruction and reduce hospital admissions 7, 8

Route of Administration

• The National Asthma Education and Prevention Program recommends oral corticosteroids as the preferred route of administration, with equivalent efficacy to IV formulations for most patients, but IV administration is preferable in severe asthma exacerbations, as stated by the Journal of Allergy and Clinical Immunology 7, 8, 9
• For severe exacerbations where patients cannot tolerate oral medications, IV methylprednisolone 125 mg or IV dexamethasone 10 mg should be used, as recommended by the American Heart Association 7, 8

Clinical Application Algorithm

• The American Heart Association recommends administering systemic corticosteroids within the first 15-30 minutes, with options including dexamethasone 16 mg PO daily for 2 days or prednisolone 30-60 mg daily for 5 days for adults, and dexamethasone 0.3 mg/kg PO single dose or 0.6 mg/kg/day for 2 days for children, with severe cases requiring IV dexamethasone 10 mg or IV methylprednisolone 125 mg 7, 8
• Reassessing at 60-90 minutes is crucial, as response to treatment predicts hospitalization need better than initial severity, according to the Journal of Allergy and Clinical Immunology 9

Common Pitfalls to Avoid

• The American College of Cardiology advises against delaying corticosteroid administration, as early use reduces hospital admissions, and against using inhaled corticosteroids alone for acute exacerbations, as systemic corticosteroids are required for moderate-to-severe cases 7, 8, 9

Simultaneous Use of Inhaled Corticosteroids and Systemic Corticosteroids for Asthma Exacerbations

Rationale for Combined Therapy

• The European Respiratory Review recommends inhaled corticosteroids like budesonide for ongoing maintenance therapy, which can be continued during exacerbations, as they serve a complementary but distinct role in managing asthma 10
• Inhaled budesonide use during exacerbations is supported by guidelines, although the severity level may not be specified, according to the European Respiratory Review 10

Clinical Application Algorithm

• The European Respiratory Review suggests continuing or initiating inhaled budesonide (Pulmicort Flexhaler) as maintenance therapy during acute exacerbations, which addresses the underlying chronic inflammation 10
• Inhaled corticosteroids alone are inadequate for acute moderate-to-severe exacerbations, and systemic corticosteroids are required, as stated in the European Respiratory Review 10